BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25388163)

  • 21. Notch signaling in pancreatic cancer: oncogene or tumor suppressor?
    Avila JL; Kissil JL
    Trends Mol Med; 2013 May; 19(5):320-7. PubMed ID: 23545339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.
    Shi Q; Xue C; Zeng Y; Yuan X; Chu Q; Jiang S; Wang J; Zhang Y; Zhu D; Li L
    Signal Transduct Target Ther; 2024 May; 9(1):128. PubMed ID: 38797752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting notch signaling pathway in cancer: clinical development advances and challenges.
    Takebe N; Nguyen D; Yang SX
    Pharmacol Ther; 2014 Feb; 141(2):140-9. PubMed ID: 24076266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
    Brechbiel J; Miller-Moslin K; Adjei AA
    Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch signaling in melanoma: interacting pathways and stromal influences that enhance Notch targeting.
    Bedogni B
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):162-8. PubMed ID: 24330305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
    Shi W; Harris AL
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible roles of DLK1 in the Notch pathway during development and disease.
    Falix FA; Aronson DC; Lamers WH; Gaemers IC
    Biochim Biophys Acta; 2012 Jun; 1822(6):988-95. PubMed ID: 22353464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch Signaling in Cancer: Rationale and Strategies for Targeting.
    Alketbi A; Attoub S
    Curr Cancer Drug Targets; 2015; 15(5):364-74. PubMed ID: 26239151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
    Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
    Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch -- a goldilocks signaling pathway in disease and cancer therapy.
    Braune EB; Lendahl U
    Discov Med; 2016 Mar; 21(115):189-96. PubMed ID: 27115169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy.
    Egloff AM; Grandis JR
    Clin Cancer Res; 2012 Oct; 18(19):5188-95. PubMed ID: 22773520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
    Purow B
    Curr Pharm Biotechnol; 2009 Feb; 10(2):154-60. PubMed ID: 19199947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch regulation of tumor angiogenesis.
    Bridges E; Oon CE; Harris A
    Future Oncol; 2011 Apr; 7(4):569-88. PubMed ID: 21463145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of EMT by Notch signaling pathway in tumor progression.
    Li Y; Ma J; Qian X; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z
    Curr Cancer Drug Targets; 2013 Nov; 13(9):957-62. PubMed ID: 24168187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOTCH signaling as a novel cancer therapeutic target.
    Miele L; Miao H; Nickoloff BJ
    Curr Cancer Drug Targets; 2006 Jun; 6(4):313-23. PubMed ID: 16848722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch inhibition as a promising new approach to cancer therapy.
    Purow B
    Adv Exp Med Biol; 2012; 727():305-19. PubMed ID: 22399357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oncogenic role of Jagged1/Notch signaling in cancer.
    Xiu MX; Liu YM; Kuang BH
    Biomed Pharmacother; 2020 Sep; 129():110416. PubMed ID: 32593969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation.
    Vo K; Amarasinghe B; Washington K; Gonzalez A; Berlin J; Dang TP
    Mol Cancer; 2011 Nov; 10():138. PubMed ID: 22074495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies.
    Gao L; Yuan K; Ding W; Lin M
    Crit Rev Eukaryot Gene Expr; 2016; 26(3):239-46. PubMed ID: 27650987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.